Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

Item
http://www.wikidata.org/entity/Q33380671
A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer.A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.Capecitabine in gastric cancer.Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.Superior antitumor activity of trastuzumab combined with capecitabine plus oxaliplatin in a human epidermal growth factor receptor 2-positive human gastric cancer xenograft model.Capecitabine for the treatment of gastric cancer.Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
P2860

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer.

Item
http://www.wikidata.org/entity/Q33380671
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Multicenter phase II study of ...... with advanced gastric cancer.
@ast
Multicenter phase II study of ...... with advanced gastric cancer.
@en
type
label
Multicenter phase II study of ...... with advanced gastric cancer.
@ast
Multicenter phase II study of ...... with advanced gastric cancer.
@en
prefLabel
Multicenter phase II study of ...... with advanced gastric cancer.
@ast
Multicenter phase II study of ...... with advanced gastric cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Multicenter phase II study of ...... with advanced gastric cancer.
@en
P2093
P304
P31
P356
10.1097/CAD.0B013E32830C457E
P433
P478
P577
P698
P921